Infographic
Features of iPSCs as Starting Materials
Summary: How can using iPSCs as starting materials help with transforming cell therapies into standard care? This infographic highlights the key features of iPSCs as starting materials, from donor consent through to commercial innovation.
View Now
Podcast
Manufacturing Cell Therapies with an Individualized Mindset
Summary: This podcast focuses on the specialized needs of manufacturing cell therapies at scale and how Custom Manufacturing Organizations are stepping in to drive process efficiencies and standardization.
View Now
Webinars
Strategies to Advance iPSC Therapies to Clinic
Summary: In this presentation, our Expert discusses efforts underway at Catalent to accelerate the path to clinic for iPSC-based therapies.
View Now
Webinars
Reengineering CAR-T for Solid Tumors
Summary: Scientists are leading a well-funded drive to adapt technology for solid tumors while making the whole process much more economical for patients and payers.
View Now
Webinars
Manufacturing Considerations for Mesenchymal Cells and Broader Allogeneic Modalities
Summary: At Catalent, we implement innovative manufacturing and fill & finish methodologies to accelerate the path to commercial for MSCs and other allogeneic modalities.
View Now
Webinars
Then and Now – Delivering a Successful Therapeutic to Patients
Summary: Experts discuss the changing experience from the last quarter of a century in the pathway to patients, and how the latest advanced technologies translate into effective pre-clinical and clinical development and manufacturing.
View Now
Webinars
Moving to Commercial Readiness with a Dedicated Analytical Platform for T-cell Therapies
Summary: Experts discuss a breadth of analytical methodologies, fill & finish approaches and manufacturing designs to accelerate CAR-T therapies to commercial readiness phase in this on-demand webinar.
View Now
eBook
Novel Approaches to Improve Cell Therapy Manufacturing
Summary: Both cell therapy innovators and manufacturing organizations are employing novel technologies and methodologies to adapt to an accelerated and evolving clinical landscape
View Now
Webinars
CAR-T Therapy: Working with a Manufacturing Partner
Summary: This roundtable is a must-watch for early and late-stage cell therapy innovator companies who are considering a manufacturing partnership.
View Now
Video
CAR-T Therapy: An Integrated Approach with an Experienced Partner
Summary: CAR-T cell therapies require expertise in process development to successfully scale-up manufacturing. Working with an integrated partner like Catalent gives you the ability to manufacture at clinical and commercial scale efficiently and effectively for both autologous and allogeneic cell therapies.
View Now